Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HPS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KANSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN2A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HIST1H2BH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHLDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRAK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATMIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PATL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AQP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB9A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMAA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSEN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on